July 26, 2021

Lexaria Receives US$3,817,643 From Warrant Exercises

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce the...
July 22, 2021

Lexaria Summarizes Successful Antiviral Drug Studies and Ongoing Strategy

Lexaria Bioscience Corp. is pleased to review its successful 2021 antiviral drug program to date and summarize expected next steps.